Thanks to years of research, doctors and health professionals now have a full menu of options to treat alcohol use disorders. Building on this progress, scientists continue to work on new medications and discover new ways to improve the effectiveness, accessibility, quality, and cost-effectiveness of treatment for people who have alcohol use disorders. What is alcoholism & how do we treat it? Alcohol Use Disorder / Kati Morton
The path to drug addiction begins with the voluntary act of taking drugs. But over time, a person's ability to choose not to do so becomes compromised. Seeking and taking the drug becomes compulsive. This is mostly due to the effects of long-term drug exposure on brain function. Addiction affects parts of the brain involved in reward and motivation, learning and memory, and control over behavior. Drug Rehab Near Me
What happens in the brain during alcohol withdrawal? GABA (gamma-aminobutyric acid) is the main calming neurotransmitter of the brain. GABA and adrenaline are supposed to be in balance during normal brain functioning. Frequent drinking causes the brain to produce less GABA, because the brain begins to rely on alcohol for part of its calming. So, frequent drinking causes your brain chemistry to be out of balance with an excess of adrenaline. When you suddenly stop drinking, your brain doesn’t have enough GABA neurotransmitter to balance the excess of adrenaline, which causes withdrawal symptoms.
The path to drug addiction begins with the voluntary act of taking drugs. But over time, a person's ability to choose not to do so becomes compromised. Seeking and taking the drug becomes compulsive. This is mostly due to the effects of long-term drug exposure on brain function. Addiction affects parts of the brain involved in reward and motivation, learning and memory, and control over behavior.
Having 24-hour supervision, intensive care, and access to treatment are some of the major benefits of inpatient rehab, as they increase the chance of recovery. Another benefit of inpatient rehab is the change in scenery. Individuals battling drugs or alcohol, or with a co-occurring disorder, often associate a particular place or even person with the struggle. For some people, it might be their basement or the local bar. For others, it might be their “drinking buddies.” And for others, just being home alone might be enough to trigger substance use or symptoms of a particular mental health disorder.
Rock Solid Recovery (men’s rehab) and its sister center, Sure Haven (women’s rehab), are highly rated, intimate treatment facilities. Treatment is based on a holistic, 12-step approach. Each facility has its own complete, multidisciplinary treatment staff, allowing patients to receive the best individualized care possible. The facilities offer inpatient treatment programs ranging from 30 days to 90 days, depending on patient needs. The primary benefit of these treatment centers is their small size. The men’s facility supports 6 patients and the women’s supports 13. This allows for the specialized, highly successful treatment that these facilities are known for.
“Most drugs start off being rewarding,” former National Institute on Drug Abuse Director Dr. Glen Hanson told DrugRehab.com. “That gets the person interested in them… As the addiction proceeds, then some of that shifts. It goes from the reward being the attraction to a compulsive behavior. Compulsive behaviors aren’t necessarily rewarding behaviors.”
Drug addiction is a chronic disease characterized by compulsive, or uncontrollable, drug seeking and use despite harmful consequences and changes in the brain, which can be long lasting. These changes in the brain can lead to the harmful behaviors seen in people who use drugs. Drug addiction is also a relapsing disease. Relapse is the return to drug use after an attempt to stop.
Nalmefene, an opiate antagonist that is similar in its chemical structure to naltrexone, is one of the most recent drugs being investigated for the treatment of alcoholism. Like naltrexone (sold as ReVia, Depade, or Vivitrol), nalmefene deprives the person struggling with substance use of the pleasurable feelings associated with drinking. But nalmefene is less toxic to the liver than naltrexone. As of 2013, nalmefene was still undergoing clinical trials through the U.S. National Institutes of Health before receiving FDA approval. From Rehab to a Body Bag | Dying for Treatment: VICE Reports (Full Length)